Journals / Turkish Journal of Gastroenterology / 2005 / Cilt: 16 - Sayı: 4

Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population

Türk toplumunda Helicobacter pylori eradikasyonu ve ülser iyileşmesinde omeprazol ve pantoprazol temelli üçlü tedavilerin kıyaslanması

Pages
242–243
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KANTARÇEKEN, B., DEMİREL, U., KARINCAOĞLU, M., ALADAĞ, M., YILDIRIM, B., SERTKAYA, A., ATEŞ, F., ÇIKIM, K., HARPUTLUOĞLU, M. M. M., ALAN, H., HİLMİOĞLU, F. (2022). Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population. Turkish Journal of Gastroenterology, Cilt: 16 - Sayı: 4, 242–243. https://ajindex.com/articles/606483

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Pension JG, McColl KE. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997; 43: 223-3
  2. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ucler relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-42
  3. Sonnenberg A. Cost-benefit analysis of testing Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol 1996; 91:1773-7
  4. Goddard A, Logan RP. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1-3
  5. Harris AW, Misiewicz JJ. Treating Helicobacter pylori - The best is yet to come? Gut 1996; 39: 781-3
  6. Jaup BH, Norrby A. Low-dose, short term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5
  7. Moayyedi P, Sahay P, Tompkins DS, et al. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835.